Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary autoimmune myelofibrosis in a 36-year-old patient presenting with isolated extreme anemia.

Literature DB >> 19748119

Primary autoimmune myelofibrosis in a 36-year-old patient presenting with isolated extreme anemia.

Fabio P S Santos, Sergej N Konoplev, Huifang Lu, Srdan Verstovsek.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Year: 2009 PMID： 19748119 PMCID： PMC4402729 DOI： 10.1016/j.leukres.2009.08.026

Source DB: PubMed Journal: Leuk Res ISSN： 0145-2126 Impact factor: 3.156

× No keyword cloud information.

10 in total

1. An uncommon association: Sjögren's syndrome and autoimmune myelofibrosis.

Authors: I Marie; H Levesque; N Cailleux; S Lepretre; C Duval; H Tilly; H Courtois
Journal: Rheumatology (Oxford) Date: 1999-04 Impact factor: 7.580

2. Autoimmune marrow fibrosis with cytopenias responsive to methotrexate.

Authors: Ioannis Giannoutsos; David Heaton
Journal: Leuk Lymphoma Date: 2006-08

Review 3. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.

Authors: David J Kuter; Barbara Bain; Ghulam Mufti; Adam Bagg; Robert P Hasserjian
Journal: Br J Haematol Date: 2007-11 Impact factor: 6.998

4. Peripheral monocytes and CD4+ cells are potential sources for increased circulating levels of TGF-beta and substance P in autoimmune myelofibrosis.

Authors: Jonathan S Harrison; Kelly E Corcoran; Deval Joshi; Constantin Sophacleus; Pranela Rameshwar
Journal: Am J Hematol Date: 2006-01 Impact factor: 10.047

Review 5. Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature.

Authors: R D Bass; V Pullarkat; D I Feinstein; A Kaul; C D Winberg; R K Brynes
Journal: Am J Clin Pathol Date: 2001-08 Impact factor: 2.493

6. European consensus on grading bone marrow fibrosis and assessment of cellularity.

Authors: Jürgen Thiele; Hans Michael Kvasnicka; Fabio Facchetti; Vito Franco; Jon van der Walt; Attilio Orazi
Journal: Haematologica Date: 2005-08 Impact factor: 9.941

Review 7. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.

Authors: R L Paquette; A Meshkinpour; P J Rosen
Journal: Medicine (Baltimore) Date: 1994-05 Impact factor: 1.889

8. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors: Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal: Blood Date: 2007-05-08 Impact factor: 22.113

9. Acute myelofibrosis in progressive systemic sclerosis. Report of a case developing during long term chlorambucil therapy and discussion of pathogenetic factors.

Authors: S D Gisser; K B Chung
Journal: Am J Med Date: 1979-07 Impact factor: 4.965

10. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.

Authors: Vinod Pullarkat; Randall D Bass; Jerald Z Gong; Donald I Feinstein; Russell K Brynes
Journal: Am J Hematol Date: 2003-01 Impact factor: 10.047